|
Heart Function Tests
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.
|
21076409 |
2010 |
|
Colorectal Carcinoma
|
0.420 |
Biomarker
|
disease |
CTD_human |
We found a colorectal carcinoma cell line harboring the fusion gene to be dependent on VTI1A-TCF7L2 for anchorage-independent growth using RNA interference-mediated knockdown.
|
21892161 |
2011 |
|
Colorectal Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Adenocarcinoma
|
0.300 |
Biomarker
|
group |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Adenocarcinoma, Basal Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Adenocarcinoma, Oxyphilic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Carcinoma, Cribriform
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Carcinoma, Granular Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Adenocarcinoma, Tubular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
Hepatitis C
|
0.010 |
Biomarker
|
disease |
BEFREE |
Follow-up assays with in vitro HCV cell culture systems validated VTI1A, a vesicular transport associated factor, which was upregulated in CoreTG but not in PA28γ(-/-)CoreTG, as a novel regulator of HCV release but not replication.
|
22646850 |
2012 |
|
Malignant neoplasm of lung
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.
|
23143601 |
2012 |
|
Carcinoma of lung
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.
|
23143601 |
2012 |
|
Colorectal Carcinoma
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we have identified novel variants of VTI1A-TCF7L2 fusion transcripts, including a novel fusion partner gene, RP11-57H14.3, and demonstrated detectable levels in a large fraction of CRC samples, as well as in normal colonic mucosa and other tissue types.
|
24608966 |
2014 |
|
Colorectal Carcinoma
|
0.420 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
Colorectal Carcinoma
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
This study reveals a new pan-ethnic CRC risk locus at 10q25 (rs12241008, intronic to VTI1A; P=1.4 × 10(-9)), providing additional insight into the aetiology of CRC and highlighting the value of association mapping in diverse populations.
|
25105248 |
2014 |
|
Colorectal Neoplasms
|
0.400 |
GeneticVariation
|
group |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
Malignant tumor of colon
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
Malignant neoplasm of large intestine
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
Adenocarcinoma of large intestine
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
Malignant neoplasm of colon and/or rectum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.
|
25105248 |
2014 |
|
Non-Small Cell Lung Carcinoma
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Multivariate regression analysis results indicated that the AA genotype of VTI1A (rs7086803) polymorphism was associated with an increased risk of developing non-small cell lung carcinoma (NSCLC) compared with the GG genotype (AA vs. GG: odds ratio [OR] = 2.020; 95% confidence interval [95% CI], 1.033-3.949, p = 0.037).
|
25744365 |
2015 |